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The dose-response relationship for biomarkers of exposure (N2-
ethylidene-dG adducts) and effect (cell survival and micronucleus 
formation) was determined across 4.5 orders of magnitude (50nM–
2mM) using [13C2]-acetaldehyde exposures to human lymphoblas-
toid TK6 cells for 12 h. There was a clear increase in exogenous 
N2-ethylidene-dG formation at exposure concentrations ≥ 1µM, 
whereas the endogenous adducts remained nearly constant across 
all exposure concentrations, with an average of 3.0 adducts/107 
dG. Exogenous adducts were lower than endogenous adducts at 
concentrations ≤ 10µM and were greater than endogenous adducts 
at concentrations ≥ 250µM. When the endogenous and exogenous 
adducts were summed together, statistically significant increases 
in total adduct formation over the endogenous background 
occurred at 50µM. Cell survival and micronucleus formation were 
monitored across the exposure range and statistically significant 
decreases in cell survival and increases in micronucleus formation 
occurred at ≥ 1000µM. This research supports the hypothesis that 
endogenously produced reactive species, including acetaldehyde, 
are always present and constitute the majority of the observed 
biological effects following very low exposures to exogenous acet-
aldehyde. These data can replace default assumptions of linear 
extrapolation to very low doses of exogenous acetaldehyde for risk 
prediction.
Key Words: acetaldehyde; DNA adduct; micronucleus; biomarker 
of exposure; biomarker of effect; liquid chromatography–mass 
spectrometry.
Acetaldehyde is a high-volume industrial chemical used 
in a diverse array of consumer and industrial applications. 
Humans are exposed to acetaldehyde through a wide variety of 
sources, including tobacco smoke, automotive emissions, and 
flavoring agents in foods and beverages (IARC Monographs 
on the Evaluation of Carcinogenic Risks to Humans, 1999; 
National Toxicology Program, 2011). It is used as the primary 
or intermediate chemical in the manufacture of a large num-
ber of industrial reagents including acetic acid, butylene gly-
col, crotonaldehyde, paraldehyde, and metaldehyde (National 
Toxicology Program, 2011). Acetaldehyde is listed as pos-
sible human carcinogen by the National Toxicology Program 
and by the International Agency for Research on Cancer 
(IARC Monographs on the Evaluation of Carciongenic Risks 
to Humans, 2010; National Toxicology Program, 2011). It is 
carcinogenic in animals, causing nasopharyngeal and laryngeal 
carcinomas in rats and hamsters following inhalation exposure 
(National Toxicology Program, 2011; Woutersen and Feron, 
1987; Woutersen et al., 1984, 1986). Acetaldehyde is produced 
following metabolism of vinyl acetate and ethanol (Bogdanffy 
and Valentine, 2003; IARC Monographs on the Evaluation of 
Carciongenic Risks to Humans, 2010). In addition to its exog-
enous sources, acetaldehyde is endogenously produced as a 
byproduct of cellular respiration and metabolism (Hazen et al., 
1998; O’Brien et al., 2005; Shin et al., 2009).
Acetaldehyde is a highly reactive 2-carbon aldehyde that 
can adduct to macromolecules including proteins and DNA 
(Balbo et al., 2008, 2012a, b; Brooks and Theruvathu, 2005; 
Chen et al., 2007; Fang and Vaca, 1995; Hecht et al., 2001a, 
b; Kuykendall and Bogdanffy, 1992a, b, 1994; Mabuchi 
et  al., 2012; Setshedi et  al., 2010; Takeshita et  al., 1997). 
Acetaldehyde reacts with DNA at primarily the N2 position of 
deoxyguanosine (dG) and forms the N2-ethylidene-dG adduct, 
which can be reduced to N2-ethyl-dG following reaction with 
a strong reducing agent (Fig. 1) (Hecht et al., 2001a, b; Wang 
et al., 2000). Acetaldehyde can also react twice with dG to form 
the 1,N2-propano-dG adduct in the presence of amino acids 
(Garcia et al., 2011; Hecht et al., 2001b). The N2-ethylidene-dG 
adduct has been detected in a number of biological systems 
including human and rodent liver, lung, buccal cells, 
lymphocytes, and granulocytes, with the majority of work 
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focusing on the formation of the adduct following ingestion of 
ethanol in humans or rodents (Chen et al., 2007; Fang and Vaca, 
1997; Matsuda et  al., 2007; Nagayoshi et  al., 2009; Oyama 
et  al., 2010; Vaca et  al., 1998). Recent studies monitoring 
the formation of DNA adducts following [13C
2
]-acetaldehyde 
exposures in a human lung fibroblast cell line (IMR-90) have 
shown the formation of exogenous 1,N2-propano-dG along 
with the N2-ethylidene-dG adducts though no values for the N2-
ethylidene-dG adduct were reported (Garcia et  al., 2011). In 
addition to directly forming DNA adducts, acetaldehyde has 
been shown to increase reactive species from oxidative stress 
and lipid peroxidation, which may also form DNA lesions 
(Garcia et al., 2011; Millonig et al., 2011).
Biomarkers of effect have been measured in a number 
of in vitro systems exposed to acetaldehyde. Acetaldehyde 
has been shown to be genotoxic in a wide range of cell lines 
and in animal models with induction of sister-chromatid 
exchange, micronuclei, DNA adducts, DNA-protein crosslinks, 
DNA-DNA crosslinks, and chromosomal aberrations (IARC 
Monographs on the Evaluation of Carcinogenic Risks to 
Humans, 1999; Kuykendall and Bogdanffy, 1992a; Speit 
et al., 2008). Acetaldehyde is a weak mutagen, showing posi-
tive results in a number of mammalian systems (Grafström 
et al., 1994; He and Lambert, 1990). Site-directed mutagenesis 
studies have investigated both the N2-ethyl-dG and the 1,N2-
propano-dG adducts, finding that the N2-ethyl-dG has a weak 
effect on blockage of replication, whereas the 1,N2-propano-dG 
is a potentially stronger mutagen (Choi and Guengerich, 2006; 
Stein et al., 2006; Terashima et al., 2001; Upton et al., 2006a, 
b; Yang et al., 2002).
Both endogenous and exogenous exposures to acetalde-
hyde are common, and there is a need to differentiate between 
both, especially at low exposures. This study is the first to use 
stable isotope exposures of [13C
2
]-acetaldehyde to differenti-
ate between endogenous and exogenous formation of the N2-
ethylidene-dG adduct and to study the effects of acetaldehyde 
on relative survival and micronucleus (MN) formation across 
exposure concentrations ranging over 4.5 orders of magni-
tude in human lymphoblastoid TK6 cells. To accomplish these 
goals, we developed a sensitive and selective liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS) method for 
the quantitation of the reduced DNA adduct (N2-ethyl-dG), and 
a flow cytometry method for assessing cell survival and MN 
formation to determine the effects of acetaldehyde exposures in 
cell culture. Data generated will enable the determination of the 
endogenous background of both biomarkers of exposure and 
effect and the contribution of exogenous acetaldehyde to those 
biomarkers in establishing possible threshold values.
MATEriAls AND METhoDs
Chemicals and materials. Acetonitrile, acetic acid, acetaldehyde, alkaline 
phosphatase, phosphodiesterase, dG, DNase I, ethyl methanesulfonate, 
high-performance liquid chromatography (HPLC)-grade water, methanol, 
MgCl
2
, N2-ethyl-dG, RPMI 1640 media, sodium phosphate, and sodium 
cyanoborohydride (NaCNBH
3





]-acetaldehyde were ordered from Cambridge Isotope 
Laboratories (Andover, MA). Sodium pyruvate, penicillin, streptomycin, and 
0.1% pluronics were purchased from Life Technologies Corporation (Carlsbad, 
CA).
Chemical hazards. Acetaldehyde is a highly reactive compound and a 
possible human carcinogen and should be handled within a fume hood.
Preparation of internal standard. The [15N
5
]-ethyl-dG internal standard 
was prepared using a modified version of previously published procedures 





 (7.5mM), acetaldehyde (2.7M), and sodium phosphate 
buffer (60mM, pH 7.2) was incubated at 37°C for 15 h. The reaction mixture 
FiG. 1. Reaction scheme for the formation of endogenous and exogenous N2-ethylidene-dG using [13C
2
]-acetaldehyde.
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was dried using a speedvac vacuum concentrator and redissolved in an aqueous 
solution of 10% methanol. The reaction mixture was injected onto an Agilent 
1200 HPLC system, and N2-ethyl-dG was purified using a Thermo Scientific 
ODS-Hypersil column (4.6 × 250 mm, 5 µm) with a flow rate of 1.5 ml/min of 
mobile phases water (A) and methanol (B). [15N
5
]-N2-Ethyl-dG was separated 
using a gradient from 5% B to 30% B for the first 20 min, followed by an 
increase to 70% B for 1 min that was reduced to 30% B and held for 2 min, 
followed by re-equilibration for 7 min at 5% B. HPLC fractions were collected 
containing [15N
5
]-N2-ethyl-dG with a retention time of 16.5 min and dried. The 
residue was redissolved and concentration determined by UV absorbance at 
254 nm with the extinction coefficient of 15,000/M cm (Wang et al., 2006).
Determination of adduct stability. For the nucleoside stability of N2-
ethylidene-dG, a solution of dG (5.8mM) and acetaldehyde (2.8M) was made 
to react in phosphate buffer (60mM, pH 7.2) for 1 h at 37°C. An aliquot of 
the reaction mixture was injected onto the Agilent 1200 HPLC system with 
mobile phases of water with 0.1% acetic acid (A) and acetonitrile with 0.1% 
acetic acid (B). The flow rate was 1.0 ml/min with a starting condition of 2% 
B, which was held for 5 min, followed by a linear gradient of 4% B at 20 min, 
10% B at 30 min, 12.5% B at 35 min, followed by 2 min at 80% B, and re-
equilibration at the starting conditions for 7 min. N2-Ethylidene-dG eluted, 
with a retention time of 28.5 min, which was collected using the fraction col-
lector. Sodium phosphate buffer was added to the solution, and the aliquots 
were stored at −80°C until being used to determine the initial amount and the 
stability of N2-ethylidene-dG. For this experiment, aliquots were held at 15°C 
inside the HPLC and injections made every 45 min. The experiment was run in 
triplicate. Aliquots were injected onto the HPLC system as mentioned previ-
ously, and peak areas were used to determine relative amounts of both dG and 
N2-ethylidene-dG.
For determination of N2-ethylidene-dG stability in DNA, calf thymus DNA 
(n = 3 experiments) was made to react with acetaldehyde (0.5M) in phosphate 
buffer for 1 h at 37°C. DNA was concentrated using an Amicon 10kD MW fil-
ter, allowing the reaction solution to be removed. DNA was recovered by add-
ing 300 µl of water to the filter, followed by mixing, and the DNA was cleaned 
by adding isopropyl alcohol. Precipitated DNA was allowed to dry, then dis-
solved in 650 µl of water, and aliquoted (~100 µg DNA per tube) into six tubes 
containing phosphate buffer (100mM, pH 7.2) for incubation at 37°C. Amount 
of N2-ethyl-dG adducts was quantitated at the following time points: 0, 3, 18, 
24, 48, and 72 h. At each time point, NaCNBH
3
 (50mM) was added to reduce 
N2-ethylidene-dG to N2-ethyl-dG. The solution was incubated for an additional 
6 h to enable the formation of more stable N2-ethyl-dG adduct. Following 
reduction, the samples were processed similarly to DNA samples from the cell 
culture experiments, and N2-ethyl-dG was quantitated by LC-MS/MS.
[13C
2
]-Acetaldehyde exposures in cell culture. Human TK6 cells were 
originally obtained in 2008 from the American Type Culture Collection 
(Manassas, VA). Cells were routinely cultured in 75 cm2 tissue culture flasks 
(Corning, NY) and maintained in RPMI 1640 medium with 10% heat-inacti-
vated horse serum plus 0.1% Pluronic, sodium pyruvate, and antibiotics (peni-




TK6 human lymphoblastoid cells (~2 × 107 cells/exposure, n = 6 per level) 
were exposed to [13C
2
]-acetaldehyde for 12 h at the following concentrations: 
0 (negative control), 0.05, 0.1, 1.0, 5.0, 10, 50, 250, 500, 1000, and 2000µM. 
Following completion of the exposure, the media were removed, and cells were 
washed and frozen at −80°C prior to DNA extraction. Cell survival and MN 
formation were determined using the identical exposure concentrations men-
tioned above in 12-well plates seeded at 8.0 × 105 cells/exposure concentration 
(n = 3).
Determination of cytotoxicity and MN frequency. A flow cytometry–
based cytotoxicity and MN assay developed by Litron Laboratories (Rochester, 
NY) was used to assess the cytotoxic and genotoxic effects of acetaldehyde in 
human TK6 cells (Bryce et al., 2007, 2008). This assay was chosen because it 
uses p53-competent human cells and has regulatory acceptance as a biomarker 
of chromosomal aberrations, and the flow-based MN assay has increased 
sensitivity compared with microscopy-based counting by scoring of 20,000 
cells for MN assessment (OECD, 2010). The flow cytometry–based cytotoxic-
ity and MN assay were performed using the In Vitro MicroFlow Kit and rea-
gents (Litron Laboratories). Sample preparation, staining, and other methods 
were performed according to the In Vitro MicroFlow Instructional Manual. 
The data were collected using a Becton-Dickinson FACSCalibur 2-laser 
4-color instrument (Becton Dickinson, San Jose, CA) as directed in the In Vitro 
MicroFlow Instructional Manual.
This flow cytometry–based method determines percent survival relative to 
unexposed controls and MN frequency in the same cell sample (Bryce et al., 
2007, 2008). Relative cell survival was determined simultaneously on the same 
sample used for MN determination using an absolute counting technique with 
6-μm latex counting beads as internal standards added during the cell prepa-
ration for flow cytometry. Relative survival was calculated using the ratio of 
counting beads to intact viable nuclei as a measure of the number of cells con-
taining intact nuclei after exposures compared with that in the vehicle controls. 
The MN frequency was determined from 20,000 (± 2000) cells analyzed from 
each sample. Media and vehicle controls were run along with the positive con-
trols and study samples.
ALDH2 genotyping of human TK6 cells. DNA was isolated from human 
TK6 cells using Qiagen Blood & Cell Culture DNA Mini Kit (Qiagen, http://
www.qiagen.com/). The genotype of the TK6 cell line for the aldehyde dehydro-
genase 2 (ALDH2) gene was determined to be wild type using direct sequencing 
of a PCR amplification product of the region of ALDH2 (exon 12) containing the 
ALDH2*1/*2 SNP. The ALDH2*2 is known to affect ALDH2 enzyme activity 
toward ethanol (SNP reference: ALDH2 rs671 SNP = A; wild type = G; rs671: 
GAA to AAA at codon 487)  (Yoshida et al., 1984). The following ALDH2-
specific primers (5′→3′) were used: CCACACTCACAGTTTTCACT—for-
ward primer and CAAATTACAGGGTCAACTG—reverse primer for the PCR 
reaction; the primer TATGATGTGTTTGGAGCC was used for sequencing 
the PCR product (Tanaka et al., 1996). The PCR conditions were as follows: 
94°C for 3 min, then 35 cycles of 94°C for 1 min, 56°C for 1 min, and 72°C 
for 1 min (for the last cycle, 72°C was for 5 min). Agarose gel electrophoresis 
demonstrated a PCR DNA band of the correct length, and this PCR product 
was submitted to Eton Biosciences (RTP, NC) for DNA sequence analysis. The 
DNA sequence from our TK6 cells matched the wild-type allele of ALDH2 
(GAA = glutamine) at the rs671 SNP location.
DNA isolation. DNA was isolated from cell pellets using the NucleoBond 
DNA Isolation Kit (Machery Nagel, Bethlehem, PA) per the manufacturer’s 
instructions. Briefly, cells were washed and lysed with the supplied buffers (G1 
and G2), followed by a 1-h incubation at 50°C with proteinase K. Following 
incubation, the DNA was extracted using the anion exchange column and 
stored at −80°C prior to analysis.
DNA reduction and digestion. DNA amounts from cells ranged from 21 
to 159 µg. Lower amounts of DNA were used in the high exposures (> 500µM) 
due to the high amount of exogenous adducts formed. DNA was thawed and 
incubated with NaCNBH
3
 (50mM) and NaPO
4
 (100mM, pH 7.2) for 6 h at 37°C 
to reduce N2-ethylidene-dG to N2-ethyl-dG. Following reduction, the DNA was 
frozen until digested (−80°C). Reduced DNA was thawed, and 200 µl of Tris/
MgCl
2
 buffer (40/10mM final concentration, pH 7.2) along with 5 fmol of the 
internal standard ([15N
5
]-N2-ethyl-dG) was added. DNA was digested with 
DNAse I  (200 units), alkaline phosphatase (5 units), and phosphodiesterase 
(0.005 units) with a 10-min preincubation with DNase I  for 1 h at 37°C. 
Following digestion, hydrolyzed DNA was filtered with a Pall Nanosep 3kDa 
filter (Port Washington, NY) at 8000 rpm for 30 min.
HPLC. Hydrolyzed DNA was injected onto an Agilent 1200 HPLC frac-
tion collection system equipped with a diode-array detector (Santa Clara, 
CA). Analytes were separated by reverse-phase liquid chromatography using 
an Atlantis C18 T3 (150 × 4.6 mm, 3  µm) column from Waters Corporation 
(Milford, MA). The mobile phases were water with 0.1% acetic acid (A) and 
acetonitrile with 0.1% acetic acid (B). The flow rate was 1.0 ml/min with a 
starting condition of 2% B, which was held for 5 min, followed by a linear 
gradient of 4% B at 20 min, 10% B at 30 min, 20% B at 40 min, 80% B at 
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45 min, which was held for 6 min, followed by re-equilibration to the starting 
conditions for 12 min. Deoxyguanosine and N2-ethyl-dG eluted, with retention 
times of 13.0 and 33.8 min, respectively. The amount of dG in samples was 
quantitated by the UV peak area (λ = 254 nm) at the corresponding retention 
time using a calibration curve ranging from 0.1 to 50 nmol dG on column.
LC-MS/MS. LC-MS/MS analyses were performed on a TSQ-Quantum 
Ultra triple-stage quadrupole mass spectrometer (Thermo Scientific, San Jose, 
CA) operated in selected reaction monitoring (SRM) mode to detect and quan-
tify N2-ethyl-dG. The mass spectrometer was interfaced with a nano-acquity 
ultra performance liquid chromatography system from Waters Corporation. 
A  0.18 × 20 mm Symmetry C18 trap column (5  µm particle size) and a 
0.1 × 100 mm HSS T3 analytical column (1.8  µm particle size) from Waters 
were used. Mobile phases were comprised of water with 0.1% acetic acid (A) 
or acetonitrile with 0.1% acetic acid (B). Analytes were first retained on a trap 
column with a flow rate of 5 µl/min of 2% mobile phase B, followed by transfer 
to the analytical column with an initial starting condition of 2% B at 0.6 µl/
min for 5 min followed by a linear gradient to 30% B over 12.5 min and to 80% 
B over 1.5 min. The flow was then held at 80% B for 1 min followed by re-
equilibration for an additional 5 min. The analytes were introduced to the MS 
using positive-mode electrospray ionization with a source voltage of 2200 V 
and no additional gases. The ion transfer tube was held at 300ºC and skimmer 
offset set to zero. Scan speed was set at 75 ms, scan width at 0.1 m/z, and a peak 
width at 0.7 m/z for Q1 and Q3. Argon was used as the collision gas and was set 
at 1.5 arbitrary units. The mass transitions used for detection and quantification 
are shown in Supplementary table SI-1. Linear calibration curves (R2 > 0.99) 
using the analyte to internal standard ratio were used to quantify the amount of 
N2-ethyl-dG in the samples (Supplementary fig. SI-1).
Statistical analysis and modeling.  The R statistical program was utilized 
for the statistical modeling (Version 2.11.0). Biomarkers of exposure and effect 
across groups were compared using Student’s t-tests (R function t-test). The 
Bonferroni-corrected p value threshold was used to account for multiple test-
ing, with p < 0.05/(number of tests) used to declare significance.
rEsulTs
Stability of N2-Ethylidene-dG as a Nucleoside and in DNA
The stability of the N2-ethylidene-dG adduct at the nucleo-
side level was assessed following the isolation of the unstable 
N2-ethylidene-dG from a reaction mixture of dG and acetalde-
hyde. The isolated adduct was injected onto the HPLC every 
45 min and the peak area used to determine the relative abun-
dance of N2-ethylidene-dG and dG (Supplementary fig. SI-2a). 
The calculated half-life (t
1/2
) of N2-ethylidene-dG at 15°C in 
phosphate buffer (pH 7.2) was 20.0 min. N2-Ethylidene-dG was 
unstable, with the primary degradation product being dG as 
shown by the increase in dG area during the incubation. No N2-
ethyl-dG was observed without the incorporation of the reduc-
tion step. In contrast to the instability of the N2-ethylidene-dG 
adduct at the nucleoside level, the adduct was more stable in 
calf thymus DNA incubated for up to 72 h at 37°C with a calcu-
lated t
1/2
 of 69.3 h (Supplementary fig. SI-2b).
LC-MS/MS Validation
The method was validated, with accuracy, precision, 
recovery, and matrix effects assessed. The limits of detec-
tion (signal:noise > 3) and quantitation (signal:noise > 10) of 
N2-ethyl-dG were 20 and 40 amol on-column, respectively 
(Supplementary fig. SI-1). Accuracy and precision were deter-
mined at three concentrations (2, 10, and 30 fmol) by adding 
N2-ethyl-dG to nonreduced control calf thymus DNA, which 
was processed similarly to study samples (Supplementary 
table SI-2). For determination of recovery and matrix effects, 
nonreduced calf thymus DNA was processed with both inter-
nal (5 fmol) and analytical (30 fmol) standards added post-
processing, along with analytical and internal standards in 
the absence of matrix. The recovery was 67%, and no matrix 
effects were observed with a % matrix effect of 100. Interassay 
(n = 6) precision and accuracy were also assessed using the 
30 fmol concentration with a % expected and % CV of 98 
and 8.8, respectively. The possible artifact formation of N2-
ethyl-dG was monitored with each run using reagent and frac-
tion collection blanks. When artifact formation was detected, 
the amount was small (ranging from nondetectable to 400 
amol) and was corrected in the determination of N2-ethyl-dG 
amounts. No artifactual formation of [13C
2
]-N2-ethyl-dG was 
observed, though with increasing amounts of N2-ethyl-dG, 
the natural isotopic distribution (0.7% of the 296.1 → 180.1 
m/z peak area) resulted in an observable peak for the 298.1 → 
182.1 m/z transition (Fig. 2). Accordingly, the area counts for 
[13C
2
]-N2-ethyl-dG chromatographic peaks were corrected by 
subtracting the expected isotopic peak area from the observed 
values to account for the isotopic contribution from endog-
enous N2-ethyl-dG.
Biomarkers of Exposure
Human lymphoblastoid TK6 cells routinely maintained in 
conditions described in the Materials and Methods section were 
exposed to [13C
2
]-acetaldehyde for 12 h at 10 concentrations 
ranging from 0.05 to 2000µM, along with nonexposed controls. 
Following completion of exposures, media containing [13C
2
]-
acetaldehyde were removed, cells washed, and cell pellets 
frozen until DNA isolation and quantitation of DNA adducts 
by LC-MS/MS. The amounts of N2-ethyl-dG, [13C
2
]-N2-
ethyl-dG, and sum of adducts (N2-ethyl-dG and [13C
2
]-N2-
ethyl-dG) were determined from replicate samples (n = 5–6/
exposure concentration) and are shown in Table 1. There were 
small changes in the endogenous adduct formation across the 
dose range though none were statistically significant compared 
with the controls. There was a clear dose-dependent increase 
in the formation of exogenous adducts with increasing [13C
2
]-
acetaldehyde exposure concentration, whereas the endogenous 
level of N2-ethyl-dG remained nearly constant with 3.0 ± 1.4 
(mean ± SD) adducts/107 dG (Fig.  3). [13C
2
]-N2-Ethyl-dG 
was not detectable at exposure concentrations < 0.1µM due 
to the natural +2 m/z isotopic abundance (~0.7%) from the 
endogenous adduct. At 0.1µM, two samples had quantifiable 
amounts of exogenous adducts (0.02 and 0.06 adducts/107 
dG). At the 1.0µM exposure concentration, a clear increase 
in [13C
2
]-N2-ethyl-dG was observed, with the exogenous peak 
equal to ~4% of the endogenous peak. This allowed for clear 
quantitation of the exogenous adducts. Exogenous adducts 
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were significantly lower (Student’s t-test, p value < 0.005 
threshold to account for 10 tests) than the corresponding 
endogenous adducts at [13C
2
]-acetaldehyde concentrations ≤ 
10µM (Table 1). Exogenous adducts were significantly higher 
(Student’s t-test, p value < 0.005) than the corresponding 
endogenous adducts at [13C
2
]-acetaldehyde concentrations ≥ 
250µM (Table  1).The sum of the adducts was significantly 
increased (Student’s t-test, Bonferroni p value < 0.005) 
from the average endogenous adducts at [13C
2
]-acetaldehyde 
concentrations ≥ 50µM (Table 1).
Exogenous [13C
2
]-N2-ethyl-dG increased with two distinct lin-
ear regions (Supplementary fig. SI-3), an initial linear increase 
in exogenous adducts from 1 to 50µM [13C
2
]-acetaldehyde 
(adducts = 0.102(x) − 0.091) and a second more steep increase 
from 250 to 2000µM [13C
2
]-acetaldehyde (adducts = 0.208(x) − 
25.3). Using a linear regression from 1 to 50μM, with an intercept 
set at the origin, exogenous adducts were extrapolated using the 
following equation (exogenous adducts = 0.100 (acetaldehyde 
concentration)). The predicted values were 0.01, 0.005, and 0 
for the 0.1, 0.05, and 0µM concentrations, respectively.
FiG. 2. Representative chromatograms. The 296.1 → 180.1 m/z transition was used to quantitate the amount of endogenous adducts, whereas the 298.1 → 
182.1 m/z transition was used to quantitate the exogenous adducts. The transition for the internal standard was 301.1 → 185.1 m/z. The natural +2 m/z isotopic 
abundance of ~0.7% of the endogenous signal can be observed in the circled chromatogram for the control TK6 cells.
TAblE 1


















mean, p value n
0 2.0 ± 0.65 N.D. 2.0 ± 0.65 — — 5
0.05 2.7 ± 1.1 N.D. 2.7 ± 1.1 — — 6
0.1 2.4 ± 0.84 0.2 ± 0.06* 2.5 ± 0.85 — — 6
1 2.7 ± 1.0 0.05 ± 0.02 2.7 ± 1.0 1.52E−03 7.06E−01 6
5 3.0 ± 1.0 0.38 ± 0.17 3.3 ± 1.0 1.19E−03 2.20E−01 6
10 3.4 ± 0.96 0.93 ± 0.42 4.2 ± 1.3 8.71E−04 2.78E−02 6
50 3.0 ± 0.79 5.0 ± 1.8 8.0 ± 2.4 6.22E−02 4.96E−03 5
250 2.8 ± 0.81 32 ± 11 34 ± 12 1.44E−03 6.16E−04 6
500 2.9 ± 1.1 78 ± 22 81 ± 22 3.94E−04 1.82E−04 6
1000 4.2 ± 1.6 180 ± 62 180 ± 61 1.05E−03 4.33E−04 6
2000 4.1 ± 3.0 390 ± 120 400 ± 120 4.84E−04 2.25E−04 6
Notes. The endogenous mean across all exposure concentrations and the control was 3.0 ± 1.4 adducts/107 dG. The sum was calculated by adding the endog-
enous and exogenous adducts from each sample, and mean and SD were calculated. A statistical comparison of exogenous and endogenous adducts was conducted 
using a t-test with a Bonferroni multiple-testing threshold for an overall false-positive rate of 0.05, corresponding to 0.005 as the threshold for each test. A second 
comparison between the sum of adducts and the endogenous mean was conducted using the same Bonferroni correction. *For the 0.1µM concentration, two sam-
ples had quantifiable amounts of exogenous adducts (shown). The remaining four samples did not have detectable levels of the exogenous adducts.
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Biomarkers of Effect
TK6 cells were exposed to the same 10 concentrations of 
[13C
2
]-acetaldehyde used for the determination of DNA adducts, 
though 12-well plates seeded at 8.0 × 105 cells/well were used for 
determination of biomarkers of effect. Following completion of 
the 12-h exposures, media were removed, cells were washed, and 
the formation of micronucleated cells and relative cell survival 
were assessed using flow cytometry (Figs. 4 and 5; Supplementary 
table SI-3). Samples were run in triplicate for each exposure 
concentration. Only one determination was made for the 2000µM 
exposure concentration due to poor sample quality. The frequency 
of MN formation was significantly greater than the vehicle control 
data at concentrations ≥ 1000µM [13C
2
]-acetaldehyde (Student’s 
t-test p value  =  0.0038, with Bonferroni-corrected p value 
FiG. 3. Endogenous versus exogenous adducts. The endogenous and exogenous N2-ethylidene-dG adducts at each exposure concentration are plotted on a 
log versus log scale. Exogenous adducts from samples with no detectable amounts are not shown. The exogenous adducts from the two samples with detectable 
amounts for the 0.1µM concentration are not shown because an average and SD could not be calculated.
FiG. 4. MN formation. The percent micronucleated cells (% MN) for each exposure concentration are shown (mean ± SD). The % MN for the vehicle control 
was 0.61 ± 0.10 (mean ± SD).
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threshold = 0.0056). Statistically significant reductions in relative 
cell survival were observed at concentrations ≥ 1000µM [13C
2
]-
acetaldehyde (Student’s t-test p value = 0.0004, with Bonferroni 
p value threshold at 0.0056). Increases in MN formation and 
decreases in cell survival were observed for concentrations 




]-acetaldehyde exposures in human TK6 lymphoblas-
toid cells showed clear changes to both biomarkers of exposure 
(DNA adducts) and effect (micronucleated cells and cell survival) 
in a dose-dependent fashion. The use of [13C
2
]-acetaldehyde 
allowed for the determination of both endogenous and exogenous 
DNA adducts and their relative contribution to the overall amount 
of adducted DNA. This information was used to determine thresh-
olds for both biomarkers of exposure and effect.
Previous studies have commented on the possible artifactual 
formation of N2-ethyl-dG during sample processing, being una-
ble to demonstrate its occurrence (Balbo et al., 2012a, b; Singh 
et  al., 2009). In contrast, a small peak at the corresponding 
retention time of N2-ethyl-dG artifact was observed using this 
methodology though the amount was minimal with less than 
0.25 adducts/107 dG found in 50 µg of DNA. Our detection of 
this small coeluting peak is likely due to the greater sensitivity 
achieved with the nanospray source employed in this method. 
The presence of the peak was monitored in reagent blanks and 
if present, subtracted from the endogenous peak areas to correct 
for the relatively small amount of increased signal.
The stability of the N2-ethylidene-dG adduct in DNA and as 
a nucleoside was determined, with a large difference in stability 
observed between the two forms of the adduct. At the nucleoside 
level, N2-ethylidene-dG rapidly degraded back to dG with a t
1/2
 
of 20 min, whereas it was markedly more stable in intact calf 
thymus DNA with a t
1/2
 of 69.3 h. The > 200× difference in sta-
bility illustrates the importance of the reduction step prior to 
enzymatic digestion of the DNA. These data do not illustrate 
the possible rates of degradation and repair in biological sys-
tems but do provide information on the stability during pro-
cessing of the samples. The rapid degradation of the nucleoside 
correlates well with previous reports on the stability of the N2-
ethylidene-dG adduct (5 min at 37°C) and shows the importance 
of the reduction step to convert the unstable adduct to the more 
stable N2-ethyl-dG allowing for analysis using LC-MS/MS 
(Wang et al., 2000). The slower t
1/2
 may be temperature depend-
ent, with degradation at 37°C occurring at a faster rate than 
at 15°C though additional studies are needed to confirm this 
relationship. Recent studies have shown that N2-ethylidene-dG 
adducts are rapidly formed and removed in buccal and white 
blood cells following ethanol consumption in human volunteers 
(Balbo et al., 2012a, b). Additional in vitro studies have shown 
that the N2-ethylidene-dG adducts are repaired in HL60 cells 
with a t
1/2
 of 35 h (Hori et al., 2012). Given these studies, it is 
likely that active repair of the N2-ethylidene-dG adduct occurs 
in humans. Further studies investigating the in vivo half-life and 
possible accumulation of N2-ethylidene-dG using stable isotope 
exposures are needed to better understand the repair or removal 
of exogenous acetaldehyde-derived DNA adducts. We have 
recently quantified N2-ethylidene-dG from nonexposed rat nasal 
mucosa with in vivo samples having higher endogenous adducts 
(~10 adducts/107 dG), illustrating that our methodology is capa-
ble of generating results similar to results of other groups.
There is considerable variation in the amount of endogenous 
N2-ethylidene-dG values reported in the literature, with 
differences observed between different tissues and in both in 
FiG. 5. Cell survival. The percent relative survival for each exposure concentration is shown (mean ± SD). The percent relative survival for the vehicle control 
was 100 ± 6.8 (mean ± SD).
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vitro and in vivo samples (Abraham et al., 2011; Balbo et al., 
2012a, b; Chen et  al., 2007; Fang and Vaca, 1997; Garcia 
et al., 2011; Hori et al., 2012; Matsuda et al., 2007; Nagayoshi 
et al., 2009; Oyama et al., 2010; Singh et al., 2009, 2012; Vaca 
et al., 1998; Wang et al., 2006). As acetaldehyde is a ubiquitous 
environmental compound, there may be considerable variation 
in human exposures due to several factors including lifestyle 
choices (food/alcohol consumption and smoking) and 
occupation. There are additional genetic components that may 
influence acetaldehyde’s potential toxicity following exposures 
in humans. ALDH2 is a well-characterized polymorphic 
enzyme primarily responsible for the clearance of acetaldehyde. 
Individuals with the ALDH2−/+ and ALDH2−/− genotyope (SNP 
genotype reference = ALDH2*2 rs671) are highly susceptible 
to the effects of acetaldehyde with markedly decreased rates 
of clearance compared with those with ALDH2+/+ genotype. 
This has been shown to be an additional risk factor for ethanol-
induced carcinogenesis (IARC Monographs on the Evaluation 
of Carciongenic Risks to Humans, 2010). The TK6 cell line is 
ALDH2+/+ although neither gene expression data nor protein 
expression data were not collected in this study. Acetaldehyde 
is also endogenously produced, with myeloperoxidase likely 
playing a key role in the endogenous production (Hazen et al., 
1998; Shin et  al., 2009). Myeloperoxidase has also been 
implicated in inflammation-induced nitrous and chlorination-
derived DNA damage (Mangerich et al., 2012). The TK6 cell 
line does not express myeloperoxidase in large amounts (Ji 
et  al., 2009), which may help explain the lower endogenous 
adducts compared with the in vivo samples.
There was a clear increase in the formation of exogenous N2-
ethylidene-dG adducts at [13C
2
]-acetaldehyde concentrations 
above 1µM. Although the exogenous adducts increased with 
increasing exposure concentrations, the endogenous adducts 
remained nearly constant. An upward trend to higher endog-
enous adducts was observed though not statistically significant 
(p = 0.24). The slight increase may be due to saturation of repair 
or metabolic clearance of endogenous acetaldehyde. The rela-
tively constant amount of endogenous N2-ethylidene-dG adducts 
observed in human TK6 cells was lower than the reported values 
obtained from human tissues including lung, liver, buccal cells, 
and lymphocyte samples (Balbo et  al., 2008, 2012a, b; Chen 
et al., 2007; Singh et al., 2009; Wang et al., 2006). This is not 
surprising given that the TK6 cells have a much faster rate of 
replication and the exposure to both endogenous and exogenous 
(food and environmental) sources is much lower in cell culture.
The lowest exposure concentration with a detectable amount 
of exogenous adducts was 0.1µM although it was not detect-
able in all the samples. Samples had a detectable peak in the 
298.1 → 182.1 m/z transition; however, the relative percentage 
of that peak to the endogenous peak was very close to the nat-
ural isotopic abundance of 0.7%, making low-level detection 
of exogenous N2-ethyl-dG more difficult. At the 1.0µM expo-
sure concentration, a clear increase in exogenous N2-ethyl-dG 
was observed, with the exogenous peak equal to ~4% of the 
endogenous peak, which allowed for clear quantitation of exog-
enous adducts. The small mass difference (+2 Da) found in the 
exogenous adducts is limited by acetaldehyde having only two 
carbons that can be stable-isotope labeled with 13C. The use 
of deuterium labels would result in larger differences in mass 
(+  1 Da/deuterium), which may allow for detection of exog-
enous adducts at lower exposure concentrations, but would be 
limited by possible differences in rates of metabolism of acet-
aldehyde and hydrogen-deuterium exchange. Acetaldehyde’s 
small size offers a limited number of positions for the incor-
poration of stable or radioactive isotopes to increase the mass 
difference between endogenous and exogenous adducts. It can 
be problematic to increase the mass difference above the natu-
ral isotopic abundance using stable isotopes. This limitation 
can be observed through other small endogenous compounds 
or exogenous compounds that form lesions identical to those of 
endogenous compounds (Swenberg et al., 2011).
The formation of exogenous adducts had two distinct lin-
ear segments over the exposure concentrations, with a change 
in slope occurring between 50 and 250µM [13C
2
]-acetaldehyde 
(Supplementary fig. SI-3). The dose-response relationship for 
the formation of exogenous adducts suggests a sublinear rela-
tionship, with a higher rate of formation of exogenous adducts 
occurring at higher acetaldehyde concentrations. The reason 
for the two distinct slopes is not known although we hypoth-
esize that it may be due to either the saturation of DNA repair 
or saturation of metabolism of acetaldehyde by the cells allow-
ing for the increase in exogenous adducts (Swenberg et  al., 
2008). It has been shown that several DNA repair pathways 
are critical to the repair of DNA lesions caused by acetalde-
hyde, with FANCD2 playing an important role (Garaycoechea 
et  al., 2013; Langevin et  al., 2011; Ridpath et  al., 2007). 
Acetaldehyde is primarily cleared following metabolism to 
acetic acid by ALDH2, which is a known polymorphic enzyme 
(IARC Monographs on the Evaluation of Carciongenic Risks 
to Humans, 2010). The metabolism of acetaldehyde to acetate 
was not monitored in this study, and the metabolic capabilities 
of the TK6 cell line for acetaldehyde are not well character-
ized. It is critical to note that acetaldehyde is primarily metabo-
lized by ALDH2 to acetate in humans (Brooks et al., 2009a; 
IARC Monographs on the Evaluation of Carcinogenic Risks to 
Humans, 1999, 2010). ALDH2 polymorphisms have been indi-
cated as an additional risk factor for ethanol-induced cancers 
in primarily northern Asians (Brooks et al., 2009a, b; Yukawa 
et al., 2012). Accordingly, this susceptible population should 
be taken into account for the assessment of risk associated with 
acetaldehyde exposures in humans.
The use of the stable isotope–labeled acetaldehyde allowed for 
the determination of the relative contribution of exogenous and 
endogenous adducts to the total amount of acetaldehyde adduction 
over more than 4 orders of magnitude. As there is no biological 
difference between endogenous and exogenous adducts, the sum 
of adducts was plotted (Fig. 6). A  t-test (Bonferroni correction, 
p < 0.005) was used to determine whether the sum of adducts 
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was statistically different from the endogenous background, 
with significant increases over background occurring at 50µM 
(p  =  0.0050) and more dramatic increases occurring at higher 
concentrations. Using our combined approach of nano-LC-MS/
MS and stable isotope exposures, we were able to quantitate the 
formation of exogenous adducts at ~50× lower concentration 
(1.0µM) than if nonlabeled acetaldehyde were utilized in the 
exposures. Additional information on the formation of exogenous 
adducts at lower exposures may be gained through the use of 14C, 
3H, or 2H to increase the mass difference between endogenous 
and exogenous adducts. Using both the sum of and the difference 
between endogenous and exogenous adducts, we clearly show that 
at low exposures (< 50µM), the additional [13C
2
]-acetaldehyde has 
no impact on the overall amount of adducted DNA.
The biological relevance of N2-ethylidene-dG in acetal-
dehyde-induced carcinogenesis is not fully characterized. 
Acetaldehyde can form other DNA lesions (DNA-protein-
crosslinks, 1,N2-propano-dG) that are known to be more bulky 
and mutagenic compared with the N2-ethyl-dG. Additional 
information of the relevance of the N2-ethylidene-dG adducts 
and other acetaldehyde-derived DNA lesions in carcinogenesis 
is needed. It is clear that acetaldehyde is a direct-acting geno-
toxic agent capable of forming a number of DNA lesions. These 
lesions may help explain the cytogenetic effects that have been 
observed following acetaldehyde exposures.
Biomarkers of exposure, including cell survival and MN for-
mation, were monitored across 10 exposure concentrations, along 
with nonexposed controls. The increased MN formation was well 
correlated with increased cytotoxicity (cell death). Statistically 
significant changes in MN formation and cell survival occurred 
at 1000µM, respectively. It should be noted that decreases in 
cell survival and increases in MN formation occurred at lower 
concentrations (250 and 500µM) though they were not statisti-
cally significant. Previous studies have reported cell survival and 
MN data in other cell lines, with statistically significant changes 
occurring at similar concentrations as observed from our results 
in the TK6 cell line (Bird et al., 1982; IARC Monographs on 
the Evaluation of Carciongenic Risks to Humans, 2010; Migliore 
et  al., 1996). The changes in cell survival and MN formation 
over the vehicle controls occurred at a 20× higher concentration 
(1000µM) than the increase in the sum of the adducts (50µM) 
over the endogenous background. This suggests that the internal 
cellular concentration of acetaldehyde, as measured by adduct 
formation, requires ~20× higher concentrations to have impact 
on this study’s biomarkers of effect. This relationship can be 
further explored by the ~1000× difference in exogenous acetal-
dehyde concentrations required to show statistically significant 
changes in the biomarkers of effect (1000µM) and the formation 
of exogenous adducts (1µM). The use of other cell lines with 
different metabolic capacities for the clearance of acetaldehyde 
may provide different dose-response relationships.
Assessing the dose-response relationship across a wide range 
of exposure conditions is critical to advancing the understanding 
of biomarkers of exposure and effects of genotoxic compounds 
to better discern the potential implications for human health. 
This study further advances such knowledge for the health 
effects of acetaldehyde by providing high-quality data for both 
endogenous and exogenous biomarkers of exposure, as well 
as biomarkers of effect across a wide range of concentrations. 
There are several critical points illustrated by the data described 
in this article. First, the use of [13C
2
]-acetaldehyde allowed for 
the discrimination between endogenous and exogenous DNA 
adducts across a wide dose range. The data clearly show that 
exogenous adducts can be extrapolated through zero. This 
FiG. 6. Sum of adducts. The mean of the endogenous adducts was 3.0 adducts/107 dG, and the sum of the adducts at each exposure concentration is shown 
(mean ± SD). The sum of the adducts for the control is not shown (2.0 ± 0.65 adducts/107 dG, mean ± SD). 
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confirms findings of other direct-acting genotoxic compounds 
(Pottenger et  al., 2009). Second, at low exogenous exposure 
conditions, the amount of endogenous DNA adducts dominates 
over the exogenous adducts. This is evident by looking at the 
sum of endogenous and exogenous adducts, which shows 
a clear threshold (>  50µM) at which additional exogenous 
acetaldehyde causes increases in the sum of acetaldehyde-
derived DNA adducts. Third, both biomarkers of effect showed 
clear thresholds (> 1000µM) at which statistically significant 
changes from the nearly constant background values occurred. 
Fourth, integrating the results from the biomarkers of exposure 
and effect clearly shows that there are differences between the 
concentrations at which these thresholds were observed. This is 
important in advancing the use of mode of action data for the 
assessment of risk of compounds such as acetaldehyde that have 
identical endogenous exposures. These data further question the 
use of default linear extrapolations and strongly support the use 
of such data for science-based regulation of genotoxic chemicals 
(Gollapudi et  al., 2012; Pottenger et  al., 2009; Pottenger and 
Gollapudi, 2009; Swenberg et al., 2008, 2011).
CoNClusioNs
The dose-response relationships for biomarkers of exposure 
(N2-ethylidene-dG adducts) and effect (cell survival and MN 
formation) were determined across 4.5 orders of magnitude 
using [13C
2
]-acetaldehyde exposures in human lymphoblastoid 
TK6 cells for 12 h. The results suggest that a threshold exists for 
both biomarkers of exposure and effect with a ~ 20-fold differ-
ence in the exposure concentrations required to achieve statisti-
cally significant changes over background levels between the 
measured biomarkers. Similar results are likely to be observed 
in animal models and human subjects following acetaldehyde 
exposures though additional studies would be needed to deter-
mine the possible human health relevance.
supplEMENTAry DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
FuNDiNG
National Institutes of Health (P42 ES005948, P30 ES010126 
to J.A.S., T32 ES007126 to B.C.M.); Vinyl Acetate Council 
(J.A.S. and L.R.). BCM was also supported by the Leon and 
Bertha Golberg Postdoctoral Fellowship. 
ACKNoWlEDGMENTs
The authors would like to acknowledge Patricia Upton for 
assistance in manuscript preparation. They would also like 
to acknowledge the support of Leonard Collins and Valeriy 
Alfonin for their assistance with LC-MS/MS instrumentation 
and the isolation of DNA from cells, respectively. The authors 
would like to acknowledge Dr Carol Swartz DVM, PhD, for 
the preparation of the formulation used for [13C
2
]-acetaldehyde 
exposures. The authors would like to acknowledge Dr Xu Tian 
for his assistance in determination of the ALDH2 genotype in 
TK6 cells.
rEFErENCEs
Abraham, J., Balbo, S., Crabb, D., and Brooks, P. J. (2011). Alcohol metabo-
lism in human cells causes DNA damage and activates the Fanconi anemia-
breast cancer susceptibility (FA-BRCA) DNA damage response network. 
Alcohol. Clin. Exp. Res. 35, 2113–2120.
Balbo, S., Hashibe, M., Gundy, S., Brennan, P., Canova, C., Simonato, L., 
Merletti, F., Richiardi, L., Agudo, A., Castellsagué, X., et  al. (2008). 
N2-ethyldeoxyguanosine as a potential biomarker for assessing effects 
of alcohol consumption on DNA. Cancer Epidemiol. Biomarkers Prev. 
17, 3026–3032.
Balbo, S., Meng, L., Bliss, R. L., Jensen, J. A., Hatsukami, D. K., and Hecht, S. 
S. (2012a). Kinetics of DNA adduct formation in the oral cavity after drink-
ing alcohol. Cancer Epidemiol. Biomarkers Prev. 21, 601–608.
Balbo, S., Meng, L., Bliss, R. L., Jensen, J. A., Hatsukami, D. K., and Hecht, S. 
S. (2012b). Time course of DNA adduct formation in peripheral blood gran-
ulocytes and lymphocytes after drinking alcohol. Mutagenesis 27, 485–490.
Bird, R. P., Draper, H. H., and Basrur, P. K. (1982). Effect of malonaldehyde 
and acetaldehyde on cultured mammalian cells. Production of micronuclei 
and chromosomal aberrations. Mutat. Res. 101, 237–246.
Bogdanffy, M. S., and Valentine, R. (2003). Differentiating between local cyto-
toxicity, mitogenesis, and genotoxicity in carcinogen risk assessments: The 
case of vinyl acetate. Toxicol. Lett. 140-141, 83–98.
Brooks, P. J., Enoch, M. A., Goldman, D., Li, T. K., and Yokoyama, A. (2009a). 
The alcohol flushing response: An unrecognized risk factor for esophageal 
cancer from alcohol consumption. PLoS Med. 6, e50.
Brooks, P. J., Goldman, D., and Li, T. K. (2009b). Alleles of alcohol and acet-
aldehyde metabolism genes modulate susceptibility to oesophageal cancer 
from alcohol consumption. Hum. Genomics 3, 103–105.
Brooks, P. J., and Theruvathu, J. A. (2005). DNA adducts from acetaldehyde: 
Implications for alcohol-related carcinogenesis. Alcohol 35, 187–193.
Bryce, S. M., Avlasevich, S. L., Bemis, J. C., Lukamowicz, M., Elhajouji, A., 
Van Goethem, F., De Boeck, M., Beerens, D., Aerts, H., Van Gompel, J., 
et al. (2008). Interlaboratory evaluation of a flow cytometric, high content in 
vitro micronucleus assay. Mutat. Res. 650, 181–195.
Bryce, S. M., Bemis, J. C., Avlasevich, S. L., and Dertinger, S. D. (2007). In 
vitro micronucleus assay scored by flow cytometry provides a comprehen-
sive evaluation of cytogenetic damage and cytotoxicity. Mutat. Res. 630, 
78–91.
Chen, L., Wang, M., Villalta, P. W., Luo, X., Feuer, R., Jensen, J., Hatsukami, 
D. K., and Hecht, S. S. (2007). Quantitation of an acetaldehyde adduct in 
human leukocyte DNA and the effect of smoking cessation. Chem. Res. 
Toxicol. 20, 108–113.
Choi, J. Y., and Guengerich, F. P. (2006). Kinetic evidence for inefficient and 
error-prone bypass across bulky N2-guanine DNA adducts by human DNA 
polymerase iota. J. Biol. Chem. 281, 12315–12324.
Fang, J. L., and Vaca, C. E. (1995). Development of a 32P-postlabelling method 
for the analysis of adducts arising through the reaction of acetaldehyde 
with 2’-deoxyguanosine-3’-monophosphate and DNA. Carcinogenesis 16, 
2177–2185.
10 MOELLER ET AL.
Fang, J. L., and Vaca, C. E. (1997). Detection of DNA adducts of acetalde-
hyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 18, 
627–632.
Garaycoechea, J. I., Crossan, G. P., Langevin, F., Daly, M., Arends, M. J., and 
Patel, K. J. (2013). Genotoxic consequences of endogenous aldehydes on 
mouse haematopoietic stem cell function. Nature 489, 571–575.
Garcia, C. C., Angeli, J. P., Freitas, F. P., Gomes, O. F., de Oliveira, T. F., Loureiro, 
A. P., Di Mascio, P., and Medeiros, M. H. (2011). [13C
2
]-Acetaldehyde pro-
motes unequivocal formation of 1,N2-propano-2’-deoxyguanosine in human 
cells. J. Am. Chem. Soc. 133, 9140–9143.
Gollapudi, B. B., Johnson, G. E., Hernandez, L. G., Pottenger, L. H., Dearfield, 
K. L., Jeffrey, A. M., Julien, E., Kim, J. H., Lovell, D. P., Macgregor, J. T., 
et al. (2012). Quantitative approaches for assessing dose-response relation-
ships in genetic toxicology studies. Environ. Mol. Mutagen. 54, 8–18.
Grafström, R. C., Dypbukt, J. M., Sundqvist, K., Atzori, L., Nielsen, I., 
Curren, R. D., and Harris, C. C. (1994). Pathobiological effects of acetal-
dehyde in cultured human epithelial cells and fibroblasts. Carcinogenesis 
15, 985–990.
Hazen, S. L., Hsu, F. F., d’Avignon, A., and Heinecke, J. W. (1998). Human 
neutrophils employ myeloperoxidase to convert alpha-amino acids to a bat-
tery of reactive aldehydes: A  pathway for aldehyde generation at sites of 
inflammation. Biochemistry 37, 6864–6873.
He, S. M., and Lambert, B. (1990). Acetaldehyde-induced mutation at the hprt 
locus in human lymphocytes in vitro. Environ. Mol. Mutagen. 16, 57–63.
Hecht, S. S., McIntee, E. J., Cheng, G., Shi, Y., Villalta, P. W., and Wang, M. 
(2001a). New aspects of DNA adduct formation by the carcinogens croton-
aldehyde and acetaldehyde. Adv. Exp. Med. Biol. 500, 63–71.
Hecht, S. S., McIntee, E. J., and Wang, M. (2001b). New DNA adducts of cro-
tonaldehyde and acetaldehyde. Toxicology 166, 31–36.
Hori, K., Miyamoto, S., Yukawa, Y., Muto, M., Chiba, T., and Matsuda, T. 
(2012). Stability of acetaldehyde-derived DNA adduct in vitro. Biochem. 
Biophys. Res. Commun. 423, 642–646.
International Agency for Research on Cancer. Monographs on the Evaluation 
of Carcinogenic Risks to Humans. Re-evaluation of some organic chemicals, 
hydrazine and hydrogen peroxide. 71, 319–335. 1999.
International Agency for Research on Cancer. Monographs on the Evaluation 
of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carba-
mate. 96, 2010.
Ji, Z., Zhang, L., Guo, W., McHale, C. M., and Smith, M. T. (2009). The ben-
zene metabolite, hydroquinone and etoposide both induce endoreduplication 
in human lymphoblastoid TK6 cells. Mutagenesis 24, 367–372.
Kanaly, R. A., Hanaoka, T., Sugimura, H., Toda, H., Matsui, S., and Matsuda, 
T. (2006). Development of the adductome approach to detect DNA damage 
in humans. Antioxid. Redox Signal. 8, 993–1001.
Kuykendall, J. R., and Bogdanffy, M. S. (1992a). Efficiency of DNA-histone 
crosslinking induced by saturated and unsaturated aldehydes in vitro. Mutat. 
Res. 283, 131–136.
Kuykendall, J. R., and Bogdanffy, M. S. (1992b). Reaction kinetics of DNA-
histone crosslinking by vinyl acetate and acetaldehyde. Carcinogenesis 13, 
2095–2100.
Kuykendall, J. R., and Bogdanffy, M. S. (1994). Formation and stability of 
acetaldehyde-induced crosslinks between poly-lysine and poly-deoxyguano-
sine. Mutat. Res. 311, 49–56.
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J., and Patel, K. J. 
(2011). Fancd2 counteracts the toxic effects of naturally produced aldehydes 
in mice. Nature 475, 53–58.
Mabuchi, R., Kurita, A., Miyoshi, N., Yokoyama, A., Furuta, T., Goda, T., 
Suwa, Y., Kan, T., Amagai, T., and Ohshima, H. (2012). Analysis of N(ε) 
-ethyllysine in human plasma proteins by gas chromatography-negative ion 
chemical ionization/mass spectrometry as a biomarker for exposure to acet-
aldehyde and alcohol. Alcohol. Clin. Exp. Res. 36, 1013–1020.
Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., 
Prestwich, E., Cui, L., McFaline, J. L., Mobley, M., Ge, Z., et al. (2012). 
Infection-induced colitis in mice causes dynamic and tissue-specific changes 
in stress response and DNA damage leading to colon cancer. Proc. Natl. 
Acad. Sci. U.S.A. 109, E1820–E1829.
Matsuda, T., Matsumoto, A., Uchida, M., Kanaly, R. A., Misaki, K., Shibutani, 
S., Kawamoto, T., Kitagawa, K., Nakayama, K. I., Tomokuni, K., et  al. 
(2007). Increased formation of hepatic N2-ethylidene-2’-deoxyguanosine 
DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with etha-
nol. Carcinogenesis 28, 2363–2366.
Migliore, L., Cocchi, L., and Scarpato, R. (1996). Detection of the centromere 
in micronuclei by fluorescence in situ hybridization: Its application to the 
human lymphocyte micronucleus assay after treatment with four suspected 
aneugens. Mutagenesis 11, 285–290.
Millonig, G., Wang, Y., Homann, N., Bernhardt, F., Qin, H., Mueller, S., 
Bartsch, H., and Seitz, H. K. (2011). Ethanol-mediated carcinogenesis in 
the human esophagus implicates CYP2E1 induction and the generation of 
carcinogenic DNA-lesions. Int. J. Cancer 128, 533–540.
Nagayoshi, H., Matsumoto, A., Nishi, R., Kawamoto, T., Ichiba, M., and 
Matsuda, T. (2009). Increased formation of gastric N(2)-ethylidene-2’-
deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice 
treated with ethanol. Mutat. Res. 673, 74–77.
National Toxicology Program. Report on Carcinogens. 2011.
O’Brien, P. J., Siraki, A. G., and Shangari, N. (2005). Aldehyde sources, metab-
olism, molecular toxicity mechanisms, and possible effects on human health. 
Crit. Rev. Toxicol. 35, 609–662.
OECD. (2010) Test No. 487: In Vitro Mammalian Cell Micronucleus Test. 7-23-
2010. OECD Publishing Paris.
Oyama, T., Nagayoshi, H., Matsuda, T., Oka, M., Isse, T., Yu, H. S., Pham, 
T. T., Tanaka, M., Kagawa, N., Kaneko, K., et al. (2010). Effects of acetal-
dehyde inhalation in mitochondrial aldehyde dehydrogenase deficient mice 
(Aldh2-/-). Front. Biosci. (Elite Ed). 2, 1344–1354.
Pottenger, L. H., and Gollapudi, B. B. (2009). A case for a new paradigm in 
genetic toxicology testing. Mutat. Res. 678, 148–151.
Pottenger, L. H., Schisler, M. R., Zhang, F., Bartels, M. J., Fontaine, D. D., 
McFadden, L. G., and Gollapudi, B. B. (2009). Dose-response and opera-
tional thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive 
mutagens, MMS and MNU. Mutat. Res. 678, 138–147.
Ridpath, J. R., Nakamura, A., Tano, K., Luke, A. M., Sonoda, E., Arakawa, H., 
Buerstedde, J. M., Gillespie, D. A., Sale, J. E., Yamazoe, M., et al. (2007). 
Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma 
levels of formaldehyde. Cancer Res. 67, 11117–11122.
Sako, M., Kawada, H., and Hirota, K. (1999). A convenient method for the 
preparation of N(2)-ethylguanine nucleosides and nucleotides. J. Org. Chem. 
64, 5719–5721.
Setshedi, M., Wands, J. R., and Monte, S. M. (2010). Acetaldehyde adducts in 
alcoholic liver disease. Oxid. Med. Cell. Longev. 3, 178–185.
Shin, H. W., Umber, B. J., Meinardi, S., Leu, S. Y., Zaldivar, F., Blake, D. R., 
and Cooper, D. M. (2009). Acetaldehyde and hexanaldehyde from cultured 
white cells. J. Transl. Med. 7, 31.
Singh, R., Gromadzinska, J., Mistry, Y., Cordell, R., Juren, T., Segerbäck, D., 
and Farmer, P. B. (2012). Detection of acetaldehyde derived N2-ethyl-2’-
deoxyguanosine in human leukocyte DNA following alcohol consumption. 
Mutat. Res. 737, 8–11.
Singh, R., Sandhu, J., Kaur, B., Juren, T., Steward, W. P., Segerbäck, D., and 
Farmer, P. B. (2009). Evaluation of the DNA damaging potential of cannabis 
cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2’-
deoxyguanosine adducts. Chem. Res. Toxicol. 22, 1181–1188.
Speit, G., Fröhler-Keller, M., Schütz, P., and Neuss, S. (2008). Low sensitivity 
of the comet assay to detect acetaldehyde-induced genotoxicity. Mutat. Res. 
657, 93–97.
 BIOMARKERS OF EXPOSURE 11
Stein, S., Lao, Y., Yang, I. Y., Hecht, S. S., and Moriya, M. (2006). Genotoxicity 
of acetaldehyde- and crotonaldehyde-induced 1,N2-propanodeoxyguanosine 
DNA adducts in human cells. Mutat. Res. 608, 1–7.
Swenberg, J. A., Fryar-Tita, E., Jeong, Y. C., Boysen, G., Starr, T., Walker, V. 
E., and Albertini, R. J. (2008). Biomarkers in toxicology and risk assess-
ment: Informing critical dose-response relationships. Chem. Res. Toxicol. 
21, 253–265.
Swenberg, J. A., Lu, K., Moeller, B. C., Gao, L., Upton, P. B., Nakamura, J., 
and Starr, T. B. (2011). Endogenous versus exogenous DNA adducts: Their 
role in carcinogenesis, epidemiology, and risk assessment. Toxicol. Sci. 
120(Suppl. 1), S130–S145.
Takeshita, T., Kawai, T., and Morimoto, K. (1997). Elevated levels of hemo-
globin-associated acetaldehyde related to alcohol drinking in the atypical 
genotype of low Km aldehyde dehydrogenase. Cancer Res. 57, 1241–1243.
Tanaka, F., Shiratori, Y., Yokosuka, O., Imazeki, F., Tsukada, Y., and Omata, 
M. (1996). High incidence of ADH2*1/ALDH2*1 genes among Japanese 
alcohol dependents and patients with alcoholic liver disease. Hepatology 23, 
234–239.
Terashima, I., Matsuda, T., Fang, T. W., Suzuki, N., Kobayashi, J., Kohda, 
K., and Shibutani, S. (2001). Miscoding potential of the N2-ethyl-2’-
deoxyguanosine DNA adduct by the exonuclease-free Klenow fragment of 
Escherichia coli DNA polymerase I. Biochemistry 40, 4106–4114.
Upton, D. C., Wang, X., Blans, P., Perrino, F. W., Fishbein, J. C., and Akman, 
S. A. (2006a). Replication of N2-ethyldeoxyguanosine DNA adducts in the 
human embryonic kidney cell line 293. Chem. Res. Toxicol. 19, 960–967.
Upton, D. C., Wang, X., Blans, P., Perrino, F. W., Fishbein, J. C., and Akman, 
S. A. (2006b). Mutagenesis by exocyclic alkylamino purine adducts in 
Escherichia coli. Mutat. Res. 599, 1–10.
Vaca, C. E., Nilsson, J. A., Fang, J. L., and Grafström, R. C. (1998). Formation 
of DNA adducts in human buccal epithelial cells exposed to acetaldehyde 
and methylglyoxal in vitro. Chem. Biol. Interact. 108, 197–208.
Wang, M., McIntee, E. J., Cheng, G., Shi, Y., Villalta, P. W., and Hecht, S. S. 
(2000). Identification of DNA adducts of acetaldehyde. Chem. Res. Toxicol. 
13, 1149–1157.
Wang, M., Yu, N., Chen, L., Villalta, P. W., Hochalter, J. B., and Hecht, S. S. 
(2006). Identification of an acetaldehyde adduct in human liver DNA and 
quantitation as N2-ethyldeoxyguanosine. Chem. Res. Toxicol. 19, 319–324.
Woutersen, R. A., Appelman, L. M., Feron, V. J., and Van der Heijden, C. A. 
(1984). Inhalation toxicity of acetaldehyde in rats. II. Carcinogenicity study: 
Interim results after 15 months. Toxicology 31, 123–133.
Woutersen, R. A., Appelman, L. M., Van Garderen-Hoetmer, A., and Feron, 
V. J. (1986). Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity 
study. Toxicology 41, 213–231.
Woutersen, R. A., and Feron, V. J. (1987). Inhalation toxicity of acetaldehyde 
in rats. IV. Progression and regression of nasal lesions after discontinuation 
of exposure. Toxicology 47, 295–305.
Yang, I. Y., Chan, G., Miller, H., Huang, Y., Torres, M. C., Johnson, F., and 
Moriya, M. (2002). Mutagenesis by acrolein-derived propanodeoxyguano-
sine adducts in human cells. Biochemistry 41, 13826–13832.
Yoshida, A., Huang, I. Y., and Ikawa, M. (1984). Molecular abnormality of 
an inactive aldehyde dehydrogenase variant commonly found in Orientals. 
Proc. Natl. Acad. Sci. U.S.A. 81, 258–261.
Yukawa, Y., Muto, M., Hori, K., Nagayoshi, H., Yokoyama, A., Chiba, T., and 
Matsuda, T. (2012). Combination of ADH1B*2/ALDH2*2 polymorphisms 
alters acetaldehyde-derived DNA damage in the blood of Japanese alcohol-
ics. Cancer Sci. 103, 1651–1655.
12 MOELLER ET AL.
